Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Comparison of sofosbuvir plus ribavirin treatment with pegylated interferon plus ribavirin treatment for chronic hepatitis C genotype 2

Digestive Diseases | Oct 28, 2017 Clinical Pharmacology

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillationârelated mild ischemic stroke: A randomized clinical trial

JAMA Neurology | Oct 27, 2017 Clinical Pharmacology

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

JAMA Neurology | Oct 27, 2017 Clinical Pharmacology

Bevacizumab in combination with platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer with or without brain metastases: A French cohort study (EOLE)

Oncology | Oct 27, 2017 Clinical Pharmacology

Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: A nationwide database-derived case-controlled study

Family Practice | Oct 27, 2017 Clinical Pharmacology

Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis

Schizophrenia Research | Oct 26, 2017 Clinical Pharmacology

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Journal of Neurology | Oct 26, 2017 Clinical Pharmacology

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin

Cardiovascular Therapeutics | Oct 26, 2017 Clinical Pharmacology

Intravenous acetaminophen does not decrease persistent surgical pain after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia | Oct 26, 2017 Clinical Pharmacology

Harmful and beneficial effects of anti-coagulants in patients with cirrhosis and portal vein thrombosis

Clinical Gastroenterology and Hepatology | Oct 26, 2017 Clinical Pharmacology

« Prev 1 … 296 297 298 299 300 … 338 Next »

Comparison of sofosbuvir plus ribavirin treatment with pegylated interferon plus ribavirin treatment for chronic hepatitis C genotype 2

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillationârelated mild ischemic stroke: A randomized clinical trial

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

Bevacizumab in combination with platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer with or without brain metastases: A French cohort study (EOLE)

Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: A nationwide database-derived case-controlled study

Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin

Intravenous acetaminophen does not decrease persistent surgical pain after cardiac surgery

Harmful and beneficial effects of anti-coagulants in patients with cirrhosis and portal vein thrombosis

Alternative Therapies and Infection Management

Managing Polypharmacy in Elderly Patients

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Recent Advances in Storage Media for Avulsed Tooth

Comparison of sofosbuvir plus ribavirin treatment with pegylated interferon plus ribavirin treatment for chronic hepatitis C genotype 2

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillationârelated mild ischemic stroke: A randomized clinical trial

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

Bevacizumab in combination with platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer with or without brain metastases: A French cohort study (EOLE)

Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: A nationwide database-derived case-controlled study

Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin

Intravenous acetaminophen does not decrease persistent surgical pain after cardiac surgery

Harmful and beneficial effects of anti-coagulants in patients with cirrhosis and portal vein thrombosis

Alternative Therapies and Infection Management

Managing Polypharmacy in Elderly Patients

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Recent Advances in Storage Media for Avulsed Tooth

Select Specialty

Select Topic

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillationârelated mild ischemic stroke: A randomized clinical trial

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)